1. Thomas HC, Lemon S, Zuckerman AJ. Viral hepatitis. 3rd ed. Massachusetts: Wiley-Blackwell; 2005. p 92-125.
4. Jacobsen KH, Koopman JS. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol 2005;34:600-609. PMID:
15831565
5. Hendrickx G, Van Herck K, Vorsters A, Wiersma S, Shapiro C, Andrus JK, et al. Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology. J Viral Hepat 2008;15 Suppl 2:1-15.
6. Song YB, Lee JH, Choi MS, Koh KC, Paik SW, Yoo BC, et al. The age-specific seroprevalence of hepatitis A virus antibody in Korea. Korean J Hepatol 2007;13:27-33 (Korean). PMID:
17380072
7. Kang JH, Lee KY, Kim CH, Sim D. Changing hepatitis A epidemiology and the need for vaccination in Korea. Asian Pac J Allergy Immunol 2004;22:237-242. PMID:
15783137
9. Sohn YM, Rho HO, Park MS, Park JH, Choi BY, Ki M, et al. The changing epidemiology of hepatitis A in children and the consideration of active immunization in Korea. Yonsei Med J 2000;41:34-39. PMID:
10731917
10. Korea Centers for Disease Control and Prevention. Viral hepatitis statistics: communicable disease sentinel surveillance . [cited 2009 Sep 20] Available from:
http://stat.cdc.go.kr/ (Korean).
11. Lee D, Cho YA, Park Y, Hwang JH, Kim JW, Kim NY, et al. Hepatitis a in Korea: epidemiological shift and call for vaccine strategy. Intervirology 2008;51:70-74.
12. Jeong SH. Current status and vaccine indication for hepatitis A virus infection in Korea. Korean J Gastroenterol 2008;51:331-337 (Korean). PMID:
18604134
13. Tarricone R. Cost-of-illness analysis. What room in health economics? Health Policy 2006;77:51-63. PMID:
16139925
14. Rice DP. Cost-of-illness studies: fact or fiction? Lancet 1994;344:1519-1520. PMID:
7983947
15. Park CS, Kang HY, Kwon I, Kang DR, Jung HY. Cost-of-illness study of asthma in Korea: estimated from the Korea national health insurance claims database. J Prev Med Public Health 2006;39:397-403 (Korean). PMID:
17076180
18. Yang BM, Kim CH, Kim JY. Cost of chronic hepatitis B infection in South Korea. J Clin Gastroenterol 2004;38:S153-S157. PMID:
15602164
19. Bauch CT, Anonychuk AM, Pham BZ, Gilca V, Duval B, Krahn MD. Cost-utility of universal hepatitis A vaccination in Canada. Vaccine 2007;25:8536-8548. PMID:
17996339
20. Kim JM, Lee YS, Lee JH, Kim W, Lim KS. Clinical outcomes and predictive factors of spontaneous survival in patients with fulminant hepatitis A. Korean J Hepatol 2008;14:474-482. PMID:
19119242
21. Jacobs RJ, Greenberg DP, Koff RS, Saab S, Meyerhoff AS. Regional variation in the cost effectiveness of childhood hepatitis A immunization. Pediatr Infect Dis J 2003;22:904-914. PMID:
14551492
22. Kim J, Lee H, Jeong H. Survey on out-of-pocket payment of national health insurance, 2007. Seoul: National Health Insurance Corporation; 2008. p 49-59.
23. National Health Insurance Corporation. 2007 national health insurance statistical yearbook. Seoul: National Health Insurance Corporation; 2008. p 180-181.
24. Ha HS. National health insurance coverage and household burden of liver transplantation. Korean J Hepatol 2005;11:S111-S114 (Korean) (author’s translation).
25. Jung YH, Ko S. The socioeconomic cost of diseases in Korea. J Prev Med Public Health 2006;39:499-504 (Korean). PMID:
17168203
28. Park CS, Kang HY, Kwon I, Kang DR, Jung HY. Cost-of-illness study of asthma in Korea: estimated from the Korea national health insurance claims database. J Prev Med Public Health 2006;39:397-403 (Korean). PMID:
17076180
29. Yang BM, Jo DS, Kim YH, Hong JM, Kim JS. The societal cost of rotavirus infection in South Korea. Korean J Pediatr 2008;51:977-986 (Korean).
31. Ki MR, Park MR, Yoo WS, Jeong BG, Park JK, Choi BY, et al. Economic analysis of vaccination and development of guidelines for control of hepatitis A virus infection, and epidemiologic analysis and development of control strategy of hepatitis C virus infection. Seoul: Korea Centers for Disease Control and Prevention; 2009. p 71 (Korean).
32. Berge JJ, Drennan DP, Jacobs RJ, Jakins A, Meyerhoff AS, Stubblefield W, et al. The cost of hepatitis A infections in American adolescents and adults in 1997. Hepatology 2000;31:469-473. PMID:
10655272
33. Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA 2005;294:202-210. PMID:
16014594
34. Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the era of vaccination. JAMA 2005;294:194-201. PMID:
16014593
35. Vacchino MN. Incidence of hepatitis A in Argentina after vaccination. J Viral Hepat 2008;15 Suppl 2:47-50. PMID:
18837834
36. Domínguez A, Oviedo M, Carmona G, Jansá JM, Borrás E, Salleras L, et al. Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain. J Viral Hepat 2008;15 Suppl 2:51-56. PMID:
18837835